Dangerous Drugs

Paxil Linked to Suicide, Birth Defects

This Alert Affects:

Women taking Paxil who delivered a child with a congenital heart defect, persistent pulmonary hypertension or other birth defect. Also, families of Paxil patients aged 18 to 24 who committed suicide.

Damages
Pregnant women taking Paxil have a greater risk of delivering children with congenital, cardiovascular or pulmonary malformations. Paxil has also been linked to suicidal tendencies in patients aged 18 to 24.
Company(ies)
Glaxo Smith Kline
Additional Details
Paxil is an anti-depressant that corrects the brain's chemical imbalance of serotonin. It is prescribed to treat depression and anxiety disorders.
Date
On Dec. 8, 2005 the FDA released a warning about birth defects associated with Paxil use. A year later, the FDA announced that Paxil must include an expanded warning detailing the possible risk of suicide for patients ages 18 to 24.
Type of Lawsuit
Mass Tort

Manufactured by GlaxoSmithKline, Paxil is an antidepressant used to treat depression and several anxiety disorders. Paxil works by correcting the brain’s chemical imbalance of serotonin. Unfortunately, young people taking the drug have developed suicidal tendencies and mothers taking the drug have seen birth defects in their newborns.

In Dec. 2006, the FDA announced that Paxil and other antidepressants are dangerous when prescribed to minors and young adults. Paxil received a label change to include a warning of suicidal thoughts in 18 to 24 year old patients. The previous warning only indicated that children under 18 were likely to develop suicidal tendencies on the drug.

In addition to causing suicidal thoughts in young people, Paxil has also been linked to birth defects. Research shows pregnant women taking Paxil during their first trimester are twice as likely to deliver a child with heart defects. Most commonly, the babies were born with holes between the two main chambers.

If your child was born with a heart defect or if a loved one has committed suicide due to Paxil use, you can seek legal help; fill out our free case evaluation form.

Oct 31, 2013
Dangerous Drugs

Judge Denies to Shrink Class Size in Paxil Birth Defect Suit

by Staff

A Canadian appeals court rejected Paxil manufacturer GlaxoSmithKline Inc.'s attempt to limit the class period in a lawsuit alleging the drug company failed to warn patients and doctors that… More

Before commenting, please review our comment policy.

Stop H.R. 985

A reckless new bill represents an unprecedented threat to consumer rights, essentially gutting class action and mass tort litigation. Congress has tried to ram it through without us noticing. Read more about the implications of this bill, and contact your members of Congress to protect your rights.

Get in Touch

By submitting this form I agree to the Terms of Use

About ClassAction.org

ClassAction.org is a group of online professionals (designers, programmers and writers) with years of experience in the legal industry. We work closely with class action and mass tort attorneys across the country and help with investigations into corporate wrongdoing.

Class Action Alerts

Sign up for our free newsletter and class action updates.

Case Resources

Hayes et al. v. Smithkline Beecham Corporation Complaint
Case number 4:07-cv-0682, U.S. District Court for the Northern District of Oklahoma
FDA Public Health Advisory, December 2005
The FDA warns that use of Paxil during the first three months of pregnancy may put unborn children at risk for birth defects, particularly heart defects.
FDA Drug Safety Communication, July 2006
The FDA warns that use of SSRIs including Paxil late in pregnancy may be linked to persistent pulmonary hypertension in newborns (PPHN), a life-threatening lung condition in children.